Article info

Original research
Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy

Authors

  • Xia Liu Division of Infectious Diseases, Allergy & Immunology and Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA PubMed articlesGoogle scholar articles
  • Fusheng Si Division of Infectious Diseases, Allergy & Immunology and Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA PubMed articlesGoogle scholar articles
  • David Bagley Division of Infectious Diseases, Allergy & Immunology and Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA PubMed articlesGoogle scholar articles
  • Feiya Ma Department of Biology, Saint Louis University, Saint Louis, Missouri, USA PubMed articlesGoogle scholar articles
  • Yuanqin Zhang Division of Infectious Diseases, Allergy & Immunology and Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA PubMed articlesGoogle scholar articles
  • Yan Tao Division of Infectious Diseases, Allergy & Immunology and Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA PubMed articlesGoogle scholar articles
  • Emily Shaw Division of Infectious Diseases, Allergy & Immunology and Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA PubMed articlesGoogle scholar articles
  • Guangyong Peng Division of Infectious Diseases, Allergy & Immunology and Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USADepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Guangyong Peng; guangyong.peng{at}health.slu.edu
View Full Text

Citation

Liu X, Si F, Bagley D, et al
Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy

Publication history

  • Accepted August 26, 2022
  • First published October 3, 2022.
Online issue publication 
December 07, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.